Safety of the sequential use of biological therapy in inflammatory bowel disease: Results from a tertiary referral centre

被引：0
|
作者：
Moens, A. [1 ,2 ]
Ballet, V. [1 ]
Sabino, J. [1 ,2 ]
Vermeire, S. [1 ,2 ]
Ferrante, M. [1 ,2 ]
机构：
[1] Univ Hosp Leuven, Dept Gastroenterol & Hepatol, Leuven, Belgium
[2] Katholieke Univ Leuven, Dept Chron Dis Metab & Ageing, Leuven, Belgium
来源：
JOURNAL OF CROHNS & COLITIS | 2020年 / 14卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
P553
引用
收藏
页码：S470 / S470
页数：1
相关论文
共 50 条
  • [21] Thioguanine use in inflammatory bowel disease: 13 year experience in a tertiary centre
    Ward, M. G.
    Kariyawasam, V. C.
    Patel, K. V.
    Elliot, T. R.
    Blaker, P. A.
    Mogan, S. B.
    Pantelidou, M.
    Anderson, S.
    Irving, P. M.
    Sanderson, J. D.
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2013, 28 : 99 - 100
  • [22] Ustekinumab Dose Intensification Is Effective in One-Third of Asian Inflammatory Bowel Disease Patients, Results From A Tertiary Inflammatory Bowel Disease Centre
    Lim, C. T.
    Tay, S. W.
    Lim, G. H.
    Salazar, E.
    Ong, W. C.
    Chan, W. P. W.
    Tan, M. T. K.
    JOURNAL OF CROHNS & COLITIS, 2023, 17 : 609 - 611
  • [23] Serological Status of Inflammatory Bowel Disease Patients Before Starting Biological Therapy - Data From a Tertiary Centre of the Best Vaccined Country
    Szanto, Kata Judit
    Rutka, Mariann
    Pigniczki, Daniella
    Farkas, Klaudia
    Burian, Katalin
    Terhes, Gabriella
    Molnar, Tamas
    INFLAMMATORY BOWEL DISEASES, 2020, 26 (04) : E28 - E28
  • [24] Inflammatory bowel disease epidemiology a tertiary centre in Brazil
    Parra, R. S.
    Feitosa, M. R.
    Ferreira, S. C.
    Caetano, B. E.
    Favoretto, A., Jr.
    Ribeiro da Rocha, J. J.
    Feres, O.
    Troncon, L. E. D. A.
    JOURNAL OF CROHNS & COLITIS, 2019, 13 : S214 - S215
  • [25] THE BURDEN OF ANEMIA REMAINS SIGNIFICANT OVER TIME IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE AT A TERTIARY REFERRAL CENTRE
    Singh, Kelita S.
    Al Khoury, Alex
    Kurti, Zsuzsanna
    Golovics, Petra
    Kohen, Rita
    Afif, Waqqas
    Wild, Gary
    Seidman, Ernest G.
    Bitton, Alain
    Bessissow, Talat
    Lakatos, Peter L.
    GASTROENTEROLOGY, 2020, 158 (06) : S938 - S939
  • [26] The burden of anaemia remains significant over time in patients with inflammatory bowel disease at a tertiary referral centre
    Singh, K. Singh
    Al-Khoury, A.
    Kurti, Z.
    Gonczi, L.
    Golovics, P.
    Kohen, R.
    Afif, W.
    Wild, G.
    Seidman, E.
    Bitton, A.
    Bessissow, T.
    Lakatos, P.
    JOURNAL OF CROHNS & COLITIS, 2020, 14 : S480 - S480
  • [27] Optimizing the use of biological therapy in patients with inflammatory bowel disease
    Moss, Alan C.
    GASTROENTEROLOGY REPORT, 2015, 3 (01): : 63 - 68
  • [28] SAFETY AND TOLERABILITY OF BIOLOGIC AGENTS IN INFLAMMATORY BOWEL DISEASE: A RETROSPECTIVE STUDY IN A TERTIARY REFERRAL CENTER
    Neve, V.
    Carparelli, S.
    Losurdo, G.
    Ierardi, E.
    Principi, M.
    Di Leo, A.
    DIGESTIVE AND LIVER DISEASE, 2019, 51 : E238 - E238
  • [29] AUDIT OF BIOLOGICAL THERAPY FOR INFLAMMATORY BOWEL DISEASE: RESULTS FROM THE UK IBD REGISTRY
    Shawihdi, Mustafa
    Cummings, Fraser
    Bloom, Stuart
    Bodger, Keith
    GUT, 2019, 68 : A97 - A98
  • [30] Outcome of Biological Therapy in Pediatric Inflammatory Bowel Disease at a Single Tertiary Center
    Nuti, Federica
    Alessandri, Claudia
    Conte, Francesca
    Civitelli, Fortunata
    Aloi, Marina
    Del Giudice, Emanuela
    Dilillo, Anna
    Oliva, Salvatore
    Viola, Franca
    Cucchiara, Salvatore
    GASTROENTEROLOGY, 2011, 140 (05) : S510 - S510
12345